Pingyong Yi

602 total citations
14 papers, 149 citations indexed

About

Pingyong Yi is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Pingyong Yi has authored 14 papers receiving a total of 149 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Pingyong Yi's work include Lymphoma Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (5 papers) and Immunotherapy and Immune Responses (3 papers). Pingyong Yi is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (5 papers) and Immunotherapy and Immune Responses (3 papers). Pingyong Yi collaborates with scholars based in China and United States. Pingyong Yi's co-authors include J Y Li, Meizuo Zhong, Yajun Li, Hui Zhou, Xianling Liu, Wenxue Ma, Hai Yu, Peizhi Fan, Lianhong Zou and Kailin Chen and has published in prestigious journals such as Cancer, World Journal of Gastroenterology and Cancer Science.

In The Last Decade

Pingyong Yi

13 papers receiving 147 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pingyong Yi China 9 75 72 40 35 20 14 149
Ricardo Fernández‐de‐Misa Spain 8 113 1.5× 73 1.0× 58 1.4× 31 0.9× 6 0.3× 25 233
M. Pilar García-Muret Spain 7 72 1.0× 99 1.4× 69 1.7× 67 1.9× 18 0.9× 12 254
Zachary Crees United States 9 69 0.9× 38 0.5× 98 2.5× 26 0.7× 15 0.8× 34 199
Emilie Sohier France 5 54 0.7× 61 0.8× 48 1.2× 18 0.5× 16 0.8× 7 128
Kaiyang Ding China 9 113 1.5× 36 0.5× 100 2.5× 46 1.3× 13 0.7× 51 241
Juliana Craig United States 8 126 1.7× 63 0.9× 50 1.3× 18 0.5× 44 2.2× 16 211
Hiroaki Kamijo Japan 11 63 0.8× 62 0.9× 65 1.6× 162 4.6× 9 0.5× 24 292
Marcin M. Machnicki Poland 8 36 0.5× 26 0.4× 55 1.4× 22 0.6× 13 0.7× 25 142
Rebecca Caeser United Kingdom 7 119 1.6× 57 0.8× 104 2.6× 64 1.8× 16 0.8× 12 213
Pedro Sánchez‐Godoy Spain 7 65 0.9× 100 1.4× 99 2.5× 33 0.9× 19 0.9× 18 220

Countries citing papers authored by Pingyong Yi

Since Specialization
Citations

This map shows the geographic impact of Pingyong Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingyong Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingyong Yi more than expected).

Fields of papers citing papers by Pingyong Yi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pingyong Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingyong Yi. The network helps show where Pingyong Yi may publish in the future.

Co-authorship network of co-authors of Pingyong Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Pingyong Yi. A scholar is included among the top collaborators of Pingyong Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pingyong Yi. Pingyong Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Zeng, Jie, Lianhong Zou, Chaojie Zhang, et al.. (2022). GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis. Frontiers in Endocrinology. 13. 995972–995972. 12 indexed citations
2.
Yi, Pingyong, et al.. (2020). A Multicenter Retrospective Study of 58 Patients With Primary Thyroid Diffuse Large B Cell Lymphoma. Frontiers in Endocrinology. 11. 542–542. 12 indexed citations
3.
Li, Yajun, J Y Li, Kailin Chen, et al.. (2020). HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases. Blood Research. 55(1). 49–56. 27 indexed citations
4.
Chen, Shuai, Pingyong Yi, Meng Fang, et al.. (2020). Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2 + Breast Cancer Cells to 5-Fluorouracil. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 28(5). 519–531. 16 indexed citations
5.
Yi, Pingyong, Wei Wang, Kunlun Li, et al.. (2019). Clinicopathological Features, Treatment, and Prognosis in Primary Diffuse Large B Cell Lymphoma of the Breast: A Retrospective Study of 46 Patients. Medical Science Monitor. 25. 8671–8682. 8 indexed citations
6.
Li, Jin, Yajun Li, Meizuo Zhong, et al.. (2018). A Multicenter Retrospective Comparison of Sequential versus Sandwich Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type. Journal of Cancer. 9(9). 1598–1606. 10 indexed citations
7.
Li, Jin, Yajun Li, Meizuo Zhong, et al.. (2018). Short-Course Versus Long-Course Chemoradiotherapy for Stage IE–IIE Extranodal Natural Killer/T cell Lymphoma, Nasal Type: A Multicenter Retrospective Study. Medical Science Monitor. 24. 2683–2692. 4 indexed citations
8.
Li, Yajun, Pingyong Yi, J Y Li, et al.. (2017). Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study. Chinese Journal of Cancer. 36(1). 62–62. 8 indexed citations
9.
Li, J Y, Yajun Li, Meizuo Zhong, et al.. (2017). Efficacy and tolerance of GELOXD/P‐GEMOXD in newly diagnosed nasal‐type extranodal NK/T‐cell lymphoma: A multicenter retrospective study. European Journal Of Haematology. 100(3). 247–256. 16 indexed citations
10.
Song, Yinghui, Meizuo Zhong, Pingping Gan, et al.. (2014). ALDH1A1 mediates resistance of diffuse large B cell lymphoma to the CHOP regimen. Tumor Biology. 35(12). 11809–11817. 9 indexed citations
11.
12.
Huang, Changxin, Hai Yu, Qingqing Wang, et al.. (2005). A novel anticancer approach: SEA-anchored tumor cells expressing heat shock protein 70 onto the surface elicit strong anticancer efficacy. Immunology Letters. 101(1). 71–80. 5 indexed citations
13.
Yi, Pingyong, Hai Yu, Wenxue Ma, Qingqing Wang, & Boris Minev. (2005). Preparation of murine B7.1‐glycosylphosphatidylinositol and transmembrane‐anchored staphylococcal enterotoxin. Cancer. 103(7). 1519–1528. 7 indexed citations
14.
Huang, Changxin, Hai Yu, Qingqing Wang, et al.. (2004). Potent antitumor effect elicited by superantigen‐linked tumor cells transduced with heat shock protein 70 gene. Cancer Science. 95(2). 160–167. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ricardo Fernández‐de‐Misa Breakdown of academic impact, for papers by M. Pilar García-Muret Breakdown of academic impact, for papers by Zachary Crees Breakdown of academic impact, for papers by Emilie Sohier Breakdown of academic impact, for papers by Kaiyang Ding Breakdown of academic impact, for papers by Juliana Craig Breakdown of academic impact, for papers by Hiroaki Kamijo Breakdown of academic impact, for papers by Marcin M. Machnicki Breakdown of academic impact, for papers by Rebecca Caeser Breakdown of academic impact, for papers by Pedro Sánchez‐Godoy
Rankless by CCL
2026